左旋多巴与金刚烷胺联合治疗帕金森病。 - Suppr

Suppr

超能文献

Combined treatment of parkinsonism with L-dopa and amantadine.

作者信息

Hunter K R, Stern G M, Laurence D R, Armitage P

出版信息

Lancet. 1970 Sep 12;2(7672):566. doi: 10.1016/s0140-6736(70)91365-6.

DOI:10.1016/s0140-6736(70)91365-6

PMID:4195220

Abstract

摘要

相似文献

Combined treatment of parkinsonism with L-dopa and amantadine.左旋多巴与金刚烷胺联合治疗帕金森病。

Lancet. 1970 Sep 12;2(7672):566. doi: 10.1016/s0140-6736(70)91365-6.

Combined treatment of parkinsonism with L-dopa and amantadine.

Lancet. 1970 Aug 22;2(7669):383-5. doi: 10.1016/s0140-6736(70)90002-4.

L-dopa and amantadine in the therapy of parkinsonism.

Wis Med J. 1969 Nov;68(11):325-8.

Combined L-dopa and amantadine in Parkinsonism.左旋多巴与金刚烷胺联合治疗帕金森病

Aust N Z J Med. 1972 Aug;2(3):252-5. doi: 10.1111/j.1445-5994.1972.tb03070.x.

[Principles for amantadine therapy in parkinsonism].[帕金森病金刚烷胺治疗原则]

Lakartidningen. 1972 Nov 8;69(46):5343-5.

Interactions of L-dopa and amantadine in patients with Parkinsonism.左旋多巴与金刚烷胺在帕金森病患者中的相互作用。

J Neurol Neurosurg Psychiatry. 1973 Jun;36(3):354-61. doi: 10.1136/jnnp.36.3.354.

Administration of amandine to patients on optimum L-dopa dosage.在最佳左旋多巴剂量下给患者使用金刚烷胺。

Acta Neurol Scand Suppl. 1972;51:119-20.

Combined treatment of Parkinson's disease with amantadine and L-dopa.

Lancet. 1970 Jun 27;1(7661):1394-5. doi: 10.1016/s0140-6736(70)91298-5.

Amantadine versus L-2 dopa and amatadine plus L-dopa.

Lancet. 1970 Jul 18;2(7664):154-5. doi: 10.1016/s0140-6736(70)92742-x.

[Clinical results of the intravenous administration of amantadine in patients with parkinsonism].[帕金森病患者静脉注射金刚烷胺的临床结果]

Minerva Med. 1971 Oct 31;62(82):3994-6.

引用本文的文献

Parkinson's disease treatment: past, present, and future.帕金森病的治疗：过去、现在和未来。

J Neural Transm (Vienna). 2020 May;127(5):785-791. doi: 10.1007/s00702-020-02167-1. Epub 2020 Mar 14.

Amantadine in Parkinson's disease.金刚烷胺在帕金森病中的应用。

Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468.

Treatment for Parkinsonism, other than levodopa.帕金森综合征的治疗，左旋多巴除外。

Br Med J. 1972 Mar 18;1(5802):741-2. doi: 10.1136/bmj.1.5802.741.

Levodopa and orphenadrine hydrochloride in Parkinsonism.

Eur J Clin Pharmacol. 1971 Dec;4(1):18-21. doi: 10.1007/BF00568893.

Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.盐酸金刚烷胺（Symmetrel）用于帕金森病的治疗：一项双盲交叉研究。

Can Med Assoc J. 1971 Jul 10;105(1):42-6 passim.

Interactions of L-dopa and amantadine in patients with Parkinsonism.左旋多巴与金刚烷胺在帕金森病患者中的相互作用。

J Neurol Neurosurg Psychiatry. 1973 Jun;36(3):354-61. doi: 10.1136/jnnp.36.3.354.

Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

Ir J Med Sci. 1974 Mar;143(2):67-78. doi: 10.1007/BF03004743.

Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.左旋多巴：对其药理特性及治疗用途的综述，特别提及帕金森病

Drugs. 1971;2(4):262-400. doi: 10.2165/00003495-197102040-00002.

Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.金刚烷胺对药物性帕金森综合征的作用：血浆水平与疗效的关系。

Br J Clin Pharmacol. 1976 Oct;3(5):883-9. doi: 10.1111/j.1365-2125.1976.tb00642.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验